This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, F.-S. Articles by Lu, C.-H. Search for Related Content PubMed PubMed Citation Articles by Liu, F.-S. Articles by Lu, C.-H.

(American Journal of Pathology. 2001;159:1629-1634.)
© 2001 American Society for Investigative Pathology

Short Communication

KAI1 Metastasis Suppressor Gene Is Frequently Down-Regulated in Cervical Carcinoma

Fu-Shing Liu^*, Jung-Ta Chen, Jin-Tang Dong^¶, Yeun-Ting Hsieh^*, Ai-Jane Lin^*, Esther Shih-Chu Ho^*, Man-Jung Hung^* and Chien-Hsing Lu^*

From the Division of Gynecologic Oncology,^*
the Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China; the Department of Obstetrics and Gynecology,
Chung Shan Medical College, Taichung, Taiwan, Republic of China; the Department of Pathology,
Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China; the Department of Pathology,
Chung Shan Medical College, Taichung, Taiwan, Republic of China; and the Department of Pathology,^¶
University of Virginia Health Sciences Center, Charlottesville, Virginia

KAI1 is a metastasis suppressor gene located on human chromosome 11p11.2. It belongs to a structurally distinct family of cell surface glycoproteins. Decreased KAI1 expression has been observed in several common solid epithelial tumors, including prostatic, pancreatic, lung, hepatic, colorectal, ovarian, and esophageal cancers. A recent study also observed frequent loss of KAI1 expression in a number of squamous cell carcinomas of the cervix by immunohistochemical technique. To further confirm whether this gene is altered in this malignancy, we analyzed KAI1 expression in various stages of cervical carcinoma by a molecular method. Total cellular RNA was extracted from 84 primary invasive cervical carcinomas and 6 metastatic or recurrent lesions. cDNA was synthesized and was used for real-time quantitative polymerase chain reaction analysis. The level of KAI1 expression was obtained as the value of threshold cycle (Ct) and was quantitated with a comparative Ct method. In addition, paraffin blocks of the tumors were selected and prepared for immunohistochemical study with an anti-KAI1 polyclonal antibody, C-16. Both the real-time quantitative polymerase chain reaction method and immunohistochemical study revealed a frequent decrease in KAI1 expression in invasive cervical cancers and metastatic or recurrent lesions. However, the reduction in KAI1 was not related to progression of the disease. When tumor cell differentiation was analyzed, poorly differentiated tumors showed a greater decrease in KAI1 expression than well or moderately differentiated tumors (P < 0.001). Histologically, KAI1 loss was observed equally in both squamous cell carcinoma and adeno-/adenosquamous carcinoma. Since down-regulation of KAI1 occurs in both early and late stages of cervical cancer, we suggest that its involvement in the progression of this malignancy is an early event.

This article has been cited by other articles:

				H. Zheng, K. Tsuneyama, C. Cheng, H. Takahashi, Z. Cui, K. Nomoto, Y. Murai, and Y. Takano Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma J. Clin. Pathol., January 1, 2007; 60(1): 50 - 56. [Abstract] [Full Text] [PDF]

				R. Bass, F. Werner, E. Odintsova, T. Sugiura, F. Berditchevski, and V. Ellis Regulation of Urokinase Receptor Proteolytic Function by the Tetraspanin CD82 J. Biol. Chem., April 15, 2005; 280(15): 14811 - 14818. [Abstract] [Full Text] [PDF]

				B. Zhou, L. Liu, M. Reddivari, and X. A. Zhang The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity Cancer Res., October 15, 2004; 64(20): 7455 - 7463. [Abstract] [Full Text] [PDF]

				J. H. Lee, S. R. Park, K.-O. Chay, Y.-W. Seo, H. Kook, K. Y. Ahn, Y. J. Kim, and K. K. Kim KAI1 COOH-Terminal Interacting Tetraspanin (KITENIN), a Member of the Tetraspanin Family, Interacts with KAI1, a Tumor Metastasis Suppressor, and Enhances Metastasis of Cancer Cancer Res., June 15, 2004; 64(12): 4235 - 4243. [Abstract] [Full Text] [PDF]

				F.-S. Liu, J.-T. Dong, J.-T. Chen, Y.-T. Hsieh, E. S.-C. Ho, M.-J. Hung, C.-H. Lu, and L.-C. Chiou KAI1 Metastasis Suppressor Protein Is Down-Regulated during the Progression of Human Endometrial Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1393 - 1398. [Abstract] [Full Text] [PDF]

				M. Schindl, P. Birner, B. Bachtiary, G. Breitenecker, E. Selzer, G. Oberhuber, and J.-T. Dong KAI1 Metastasis Suppressor Protein in Cervical Cancer Am. J. Pathol., April 1, 2002; 160(4): 1542 - 1543. [Full Text] [PDF]